Target intelligence / Profile preview

Slingshot homolog 1 mRNA (SSH1 mRNA)

Target
SSH1 mRNA
Molecular classification
Messenger RNA, Nucleic acid
01

Overview

Slingshot homolog 1 (SSH1) mRNA encodes a protein phosphatase that plays a critical role in regulating the actin cytoskeleton by specifically dephosphorylating and activating cofilin. The SSH1-cofilin pathway is a central regulator of actin filament dynamics, which is essential for processes such as cell migration, division, and intracellular transport. In the context of oncology, SSH1 is frequently overexpressed in various cancers, where it promotes tumor cell invasion and metastasis by enhancing lamellipodia formation and motility. In neurodegenerative conditions like Alzheimer's disease, overactive SSH1 leads to excessive cofilin activation, contributing to the formation of cofilin-actin rods that disrupt axonal transport and synaptic function. Targeting the SSH1 mRNA via RNA interference (siRNA) or antisense oligonucleotides (ASOs) aims to reduce the total pool of SSH1 protein, thereby modulating cofilin activity to inhibit cancer progression or neurodegeneration. While currently primarily in the experimental and preclinical stages, SSH1 mRNA represents a promising target for precision medicine in diseases characterized by aberrant cytoskeletal remodeling.

Other names
SSH1L mRNASlingshot-1L mRNASSH-1L mRNAhSSH1L mRNAProtein phosphatase Slingshot homolog 1 mRNA
02

Mechanism of action

RNA interference (siRNA-mediated degradation), RNase H-mediated cleavage (ASO-mediated degradation), Translation inhibition

03

Biological functions

Regulation of actin cytoskeletonCofilin dephosphorylationCell migrationNeurite outgrowthProtein dephosphorylationChemotaxis
04

Disease associations

Cancer (Metastasis)Alzheimer's diseaseNeurodegenerative diseaseInflammation
05

Safety considerations

Off-target effects on other Slingshot isoforms (SSH2, SSH3)Disruption of essential actin-dependent cellular processesSystemic toxicity of RNA delivery vehiclesPotential for impaired wound healing or immune cell motility
06

Interacting drugs

SSH1-targeted siRNA

1 more in the full profile.

07

Biomarkers

SSH1 protein expression levelsPhospho-cofilin (p-cofilin) levelsCofilin-actin rod formationF-actin/G-actin ratio

Beyond the preview

Go deeper on Slingshot homolog 1 mRNA (SSH1 mRNA).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Slingshot homolog 1 mRNA (SSH1 mRNA).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call